Benchmark Maintains Buy on Proto Labs, Raises Price Target to $91

Benzinga Newsdesk www.benzinga.com Positive 65.8%

Neg 0% Neu 0% Pos 65.8%

Benchmark analyst Robert Wasserman maintains Proto Labs (NYSE:PRLB) with a Buy and raises the price target from $70 to $91.